Therapyx, Inc entered the industry of Commercial Biotechnical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code , which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Thomas Conway by calling (716) 829-2528 during business hours. You can also write to the business’ Single Location at 3435 Main St
Farber Hall, Buffalo, New York NY 14221. You can also visit the company’s website at therapyxinc.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Therapyx, Inc |
Representative: | Thomas Conway |
Place of Business: | 3435 Main St Farber Hall, Buffalo, NY 14221 |
Contact Number: | (716) 829-2528 |
Website: | therapyxinc.com |
Type of Service: | Commercial Biotechnical Research |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2002 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Therapyx, Inc is a company operating from Erie, New York providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code as Commercial Biotechnical Research, and with the NAICS code as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Therapyx, Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Thomas Conway at (716) 829-2528 for related queries, or to locate its Single Location using the coordinates +42.967886,-078.733494.
The Single Location can also be found at the street address 3435 Main St
Farber Hall in Buffalo, New York 14221 and can be engaged online through the company website at therapyxinc.com, the company Twitter , and Facebook page .